华润双鹤(600062.SH)：盐酸吡格列酮分散片获得药品补充申请批准通知书

智通财经2025-12-01

智通财经APP讯，华润双鹤(600062.SH)发布公告，近日，公司控股子公司双鹤天安药业(贵州)股份有限公司(简称“双鹤天安”)收到了国家药品监督管理局颁发的盐酸吡格列酮分散片《药品补充申请批准通知书》。经审查，该药品视同通过仿制药质量和疗效一致性评价。盐酸吡格列酮分散片用于2型糖尿病的治疗。本次盐酸吡格列酮分散片通过一致性评价将有利于未来的市场销售和市场竞争，并为后续开展仿制药一致性评价积累了...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2588723866?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-12-01 17:20","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588723866","market":"fut","top_or_hot":-1,"title":"华润双鹤(600062.SH)：盐酸吡格列酮分散片获得药品补充申请批准通知书","media":"智通财经","content":"<div>\n<p>智通财经APP讯，华润双鹤(600062.SH)发布公告，近日，公司控股子公司双鹤天安药业(贵州)股份有限公司(简称“双鹤天安”)收到了国家药品监督管理局颁发的盐酸吡格列酮分散片《药品补充申请批准通知书》。经审查，该药品视同通过仿制药质量和疗效一致性评价。盐酸吡格列酮分散片用于2型糖尿病的治疗。本次盐酸吡格列酮分散片通过一致性评价将有利于未来的市场销售和市场竞争，并为后续开展仿制药一致性评价积累了...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1376008.html\">网页链接</a>\n\n</div>\n","source":"stock_zhitongcaijing","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>华润双鹤(600062.SH)：盐酸吡格列酮分散片获得药品补充申请批准通知书</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n华润双鹤(600062.SH)：盐酸吡格列酮分散片获得药品补充申请批准通知书\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-12-01 17:20 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/1376008.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP讯，华润双鹤(600062.SH)发布公告，近日，公司控股子公司双鹤天安药业(贵州)股份有限公司(简称“双鹤天安”)收到了国家药品监督管理局颁发的盐酸吡格列酮分散片《药品补充申请批准通知书》。经审查，该药品视同通过仿制药质量和疗效一致性评价。盐酸吡格列酮分散片用于2型糖尿病的治疗。本次盐酸吡格列酮分散片通过一致性评价将有利于未来的市场销售和市场竞争，并为后续开展仿制药一致性评价积累了...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/1376008.html\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0175","symbol_name":"白马股","start_time":0,"source_url":"http://www.zhitongcaijing.com/content/detail/1376008.html","article_id":"2588723866","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2588723866","pubTimestamp":1764580822,"columns":[],"sourceInfo":{"source_id":"stock_zhitongcaijing","name":"智通财经网"},"weMediaInfo":null,"summary":"智通财经APP讯，华润双鹤(600062.SH)发布公告，近日，公司控股子公司双鹤天安药业(贵州)股份有限公司(简称“双鹤天安”)收到了国家药品监督管理局颁发的盐酸吡格列酮分散片《药品补充申请批准通知书》。经审查，该药品视同通过仿制药质量和疗效一致性评价。盐酸吡格列酮分散片用于2型糖尿病的治疗。本次盐酸吡格列酮分散片通过一致性评价将有利于未来的市场销售和市场竞争，并为后续开展仿制药一致性评价积累了宝贵的经验。","collect":0,"end_time":0,"defaultTopTitle":"zhitongcaijing.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"600062":"华润双鹤","BK0175":"白马股","BK0010":"央企","BK0185":"二线龙头","BK0239":"医药制造","BK0028":"国家队","BK0188":"融资融券"},"translate_title":"China Resources Shuanghe (600062. SH): Pioglitazone Hydrochloride Dispersible Tablets Obtained Approval Notice for Supplementary Drug Application","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"600062":1.5},"content_text":"智通财经APP讯，华润双鹤(600062.SH)发布公告，近日，公司控股子公司双鹤天安药业(贵州)股份有限公司(简称“双鹤天安”)收到了国家药品监督管理局颁发的盐酸吡格列酮分散片《药品补充申请批准通知书》。经审查，该药品视同通过仿制药质量和疗效一致性评价。盐酸吡格列酮分散片用于2型糖尿病的治疗。本次盐酸吡格列酮分散片通过一致性评价将有利于未来的市场销售和市场竞争，并为后续开展仿制药一致性评价积累了宝贵的经验。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2588723866","isCrawlerRequest":true}